| Literature DB >> 26853061 |
Lorna Trenchard1, Louise Mc Grath-Lone2, Helen Ward2.
Abstract
OBJECTIVE: Ethnic inequalities in cancer patient experience exist but variation within broad ethnic categories is under-explored. This study aimed to describe variation by ethnic sub-category in experiences of information provision and communication (key domains of patient experience) using National Cancer Patient Experience Survey (NCPES) data.Entities:
Keywords: Cancer; communication; ethnicity; information provision; patient experience
Mesh:
Year: 2016 PMID: 26853061 PMCID: PMC4940888 DOI: 10.1080/13557858.2015.1126561
Source DB: PubMed Journal: Ethn Health ISSN: 1355-7858 Impact factor: 2.772
Selected characteristics of respondents to 2012–2013 NCPES.
| % | Tumour group | % | |||
|---|---|---|---|---|---|
| Gender | |||||
| Male | 31,060 | 45.2 | Brain/central nervous system | 730 | 1.1 |
| Female | 35,358 | 51.4 | Breast | 13,916 | 20.2 |
| Colorectal/lower gastrointestinal | 8899 | 12.9 | |||
| Age group | Gynaecological | 3896 | 5.7 | ||
| 16–25 | 257 | 0.4 | Haematological | 11,602 | 16.9 |
| 26–35 | 904 | 1.3 | Head and neck | 2437 | 3.5 |
| 36–50 | 6150 | 8.9 | Lung | 5018 | 7.3 |
| 51–65 | 20,324 | 29.6 | Other | 2739 | 4.0 |
| 66–75 | 22,539 | 32.8 | Prostate | 5585 | 8.1 |
| 76+ | 15,571 | 22.7 | Sarcoma | 720 | 1.0 |
| Skin | 1854 | 2.7 | |||
| Ethnicitya | Upper gastrointestinal | 4283 | 6.2 | ||
| White | 63,434 | 92.3 | Urological | 7058 | 10.3 |
| Time since first treatment | |||||
| <1 year | 43,687 | 63.6 | |||
| 1–5 years | 16,498 | 24.0 | |||
| Mixed | 323 | 0.5 | >5 years | 5647 | 8.2 |
| Employment status | |||||
| Full time employment | 10,861 | 15.8 | |||
| Part time employment | 5868 | 8.5 | |||
| Homemaker | 1805 | 2.6 | |||
| Asian or Asian British | 1185 | 1.7 | Student | 178 | 0.3 |
| Retired | 41,339 | 60.1 | |||
| Unemployed, seeking work | 466 | 0.7 | |||
| Unable to work for health reasons | 3773 | 5.5 | |||
| Other | 1424 | 2.1 | |||
| Black or Black British | 923 | 1.3 | Patient classification | ||
| Day case | 44,295 | 64.4 | |||
| Inpatient | 24,442 | 35.6 | |||
| Cancer response to treatment | |||||
| Chinese | 170 | 0.2 | Has responded fully (no signs/symptoms) | 24,442 | 35.5 |
| Has been treated but is still present | 17,089 | 24.5 | |||
| Any other ethnic group | 112 | 0.2 | Has not been treated at all | 1166 | 1.7 |
| Has come back after it was treated | 3564 | 5.2 | |||
| Long-standing conditionsb | Has responded fully, but have a new cancer | 1926 | 2.8 | ||
| None | 40,403 | 58.8 | Not certain what is happening | 13,996 | 20.4 |
| Deafness or hearing impairment | 7040 | 10.2 | |||
| Blindness or visually impairment | 1533 | 2.3 | National IMD Quintile | ||
| Physical condition | 9045 | 13.2 | 1 (Least deprived) | 16,413 | 23.9 |
| Learning disability | 290 | 0.4 | 2 | 16,412 | 23.9 |
| Mental health condition | 1339 | 2.0 | 3 | 14,492 | 21.1 |
| Long-standing illnessc | 8917 | 13.0 | 4 | 11,840 | 17.2 |
| 5 (Most deprived) | 9221 | 13.4 |
aEthnic sub-categories are italicised.
bPatients may have multiple long-standing conditions (therefore the column total may exceed 100%).
cSuch as (but not limited to) HIV, diabetes or chronic heart disease. Gender was unknown for 3.4% of respondents (n = 2319), age group for 4.4% (n = 2992), ethnicity for 3.8% (n = 2590), long-standing conditions for 9.0% (n = 6175), time since first treatment for 4.2% (n = 2905), employment status for 4.4% (n = 3023), response to treatment for 9.6% (n = 6574) and IMD quintile for 0.5% (n = 359).
Proportion of patients rating their overall care positively, by ethnic broad and sub-category.
| Ethnicity | % | OR | 95% CI | ORadja | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
| White (all) | 52,664 | 89.4 | (ref)b | (ref)b | ||||
| Mixed (all) | 258 | 81.0 | 0.50 | 0.37–0.69 | 0.53 | 0.38–0.73 | ||
| Asian or Asian British (all) | 955 | 73.6 | 0.33 | 0.29–0.38 | 0.34 | 0.29–0.40 | ||
| Black or Black British (all) | 669 | 78.9 | 0.44 | 0.37–0.53 | 0.48 | 0.40–0.59 | ||
| Chinese | 140 | 72.9 | 0.31 | 0.21–0.47 | 0.33 | 0.22–0.48 | ||
| Any other ethnic group | 92 | 75.0 | 0.35 | 0.22–0.57 | 0.43 | 0.26–0.71 | ||
| White British | 50,901 | 89.6 | (ref)c | (ref)c | ||||
| White Irish | 741 | 88.0 | 0.85 | 0.68–1.06 | .16 | 0.88 | 0.70–1.11 | .28 |
| Any other White background | 1022 | 82.4 | 0.55 | 0.46–0.64 | 0.58 | 0.49–0.69 | ||
| White & Black Caribbean | 74 | 81.1 | 0.50 | 0.37–0.69 | 0.49 | 0.27–0.89 | ||
| White & Black African | 30 | 76.7 | 0.38 | 0.28–0.89 | 0.41 | 0.17–0.99 | ||
| White & Asian | 85 | 82.4 | 0.54 | 0.31–0.95 | 0.55 | 0.31–0.98 | ||
| Any other Mixed background | 69 | 81.2 | 0.50 | 0.27–0.91 | 0.51 | 0.28–0.95 | ||
| Indian | 497 | 72.4 | 0.33 | 0.25–0.37 | 0.31 | 0.25–0.38 | ||
| Pakistani | 199 | 73.4 | 0.33 | 0.24–0.44 | 0.31 | 0.22–0.43 | ||
| Bangladeshi | 48 | 54.2 | 0.15 | 0.08–0.24 | 0.16 | 0.09–0.29 | ||
| Any other Asian background | 211 | 81.0 | 0.51 | 0.35–0.70 | 0.55 | 0.38–0.78 | ||
| Caribbean | 368 | 77.2 | 0.41 | 0.31–0.50 | 0.43 | 0.33–0.55 | ||
| African | 270 | 81.5 | 0.52 | 0.38–0.70 | 0.53 | 0.38–0.73 | ||
| Any other Black background | 31 | 77.4 | 0.41 | 0.17–0.96 | 0.47 | 0.20–1.11 | .09 | |
| Chinese | 140 | 72.9 | 0.31 | 0.21–0.47 | 0.33 | 0.22–0.48 | ||
| Any other ethnic group | 92 | 75.0 | 0.35 | 0.22–0.57 | 0.43 | 0.26–0.71 |
Note: Analysis was restricted to 54,778 respondents and excluded patients who did not respond to Q70 (n = 2538) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quantile (n = 11,421). Significant associations (p < .05) are highlighted in bold. According to the likelihood ratio test, the model using ethnic sub-categories was significantly better than the model using broad categories (χ 2(10) = 52.00, p < .001).
aAdjusted for age, gender, long-standing condition, time since first treatment, tumour group, patient classification, response to treatment, IMD and Trust.
bFor comparisons by broad ethnic categories, the reference group was White patients.
cFor comparisons by ethnic sub-categories, the reference group was White British patients.
Composite positive scores for questions related to communication and information provision along the cancer care pathway by ethnic broad and sub-category.
| Diagnosis (%) | Diagnostic tests (%) | Treatment side effects (%) | Operations (%) | Support (%) | Leaving hospital (%) | |
|---|---|---|---|---|---|---|
| All patients | 72.0 | 84.2 | 70.6 | 71.5 | 79.4 | 88.9 |
| White (all) | 72.3 | 84.6 | 70.8 | 71.6 | 79.5 | 88.9 |
| Mixed | 67.4 | 79.7 | 67.4 | 68.0 | 78.4 | 86.7 |
| Asian or Asian British | 64.4 | 74.8 | 68.2 | 68.4 | 75.0 | 89.0 |
| Black or Black British | 65.6 | 77.1 | 65.5 | 70.1 | 79.0 | 86.6 |
| Chinese | 57.8 | 72.3 | 67.0 | 64.4 | 67.1 | 86.5 |
| Any other ethnic group | 67.1 | 74.3 | 70.2 | 67.9 | 73.8 | 82.8 |
| White British | 72.3 | 84.6 | 70.7 | 71.5 | 79.5 | 89.0 |
| White Irish | 73.4 | 87.0 | 74.4 | 75.2 | 82.2 | 89.1 |
| Any other White background | 73.3 | 82.7 | 72.9 | 73.5 | 78.3 | 87.2 |
| White & Black Caribbean | 67.8 | 81.6 | 66.7 | 69.8 | 75.0 | 89.4 |
| White & Black African | 68.8 | 88.2 | 70.3 | 64.8 | 86.1 | 90.7 |
| White & Asian | 63.9 | 75.0 | 66.3 | 67.1 | 72.8 | 84.7 |
| Any other Mixed background | 70.5 | 79.7 | 68.3 | 68.6 | 83.6 | 84.4 |
| Indian | 64.7 | 72.5 | 67.1 | 68.5 | 73.5 | 89.3 |
| Pakistani | 63.1 | 76.9 | 67.8 | 67.2 | 75.5 | 86.1 |
| Bangladeshi | 55.3 | 64.2 | 55.3 | 61.6 | 62.8 | 78.5 |
| Any other Asian background | 67.4 | 80.7 | 74.4 | 70.8 | 80.4 | 93.9 |
| Caribbean | 66.4 | 76.6 | 64.7 | 67.2 | 77.9 | 85.8 |
| African | 64.7 | 77.5 | 65.7 | 73.5 | 79.6 | 86.7 |
| Any other Black background | 63.9 | 79.6 | 72.8 | 71.9 | 86.1 | 95.7 |
| Chinese | 57.8 | 72.3 | 67.0 | 64.4 | 67.1 | 86.5 |
| Any other ethnic group | 67.1 | 74.3 | 70.2 | 67.9 | 73.8 | 82.8 |
Note: Composite positive scores were calculated as the unweighted average of the proportion of positive respondents for the constituent questions (as described in Appendix).
Variation in communication about the side effects of treatment, by ethnicity.
| Ethnicity | % | OR | 95% CI | ORadja | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
| (a) Given an understandable explanation of side effects of treatmentb | ||||||||
| White | 37,649 | 75.3 | (ref)c | (ref)c | ||||
| Mixed | 176 | 72.1 | 0.85 | 0.64–1.12 | .25 | 0.83 | 0.62–1.10 | .20 |
| Asian or Asian British | 658 | 70.5 | 0.78 | 0.68–0.90 | 0.78 | 0.67–0.90 | ||
| Black or Black British | 454 | 69.5 | 0.75 | 0.63–0.89 | 0.74 | 0.63–0.89 | ||
| Chinese | 93 | 69.9 | 0.76 | 0.53–1.10 | .15 | 0.72 | 0.50–1.06 | .09 |
| Any other ethnic group | 68 | 75.6 | 1.01 | 0.63–1.64 | .96 | 1.04 | 0.64–1.70 | .88 |
| White British | 36,304 | 75.2 | (ref)d | (ref)d | ||||
| White Irish | 571 | 79.3 | 1.26 | 1.05–1.51 | 1.30 | 1.08–1.56 | ||
| Any other White background | 774 | 78.0 | 1.16 | 1.00–1.36 | 1.16 | 0.99–1.35 | .06 | |
| White & Black Caribbean | 49 | 70.0 | 0.77 | 0.46–1.28 | .31 | 0.76 | 0.46–1.28 | .31 |
| White & Black African | 24 | 80.0 | 1.32 | 0.54–3.22 | .55 | 1.26 | 0.51–3.13 | .61 |
| White & Asian | 62 | 76.5 | 1.08 | 0.64–1.80 | .78 | 1.06 | 0.63–1.79 | .82 |
| Any other Mixed background | 41 | 65.1 | 0.61 | 0.37–1.03 | .07 | 0.61 | 0.36–1.03 | .06 |
| Indian | 337 | 69.3 | 0.75 | 0.61–0.91 | 0.75 | 0.61–0.91 | ||
| Pakistani | 143 | 73.7 | 0.92 | 0.67–1.27 | .63 | 0.89 | 0.65–1.24 | .50 |
| Bangladeshi | 21 | 45.7 | 0.28 | 0.16–0.50 | 0.30 | 0.17–0.55 | ||
| Any other Asian background | 157 | 75.9 | 1.03 | 0.75–1.42 | .84 | 1.05 | 0.76–1.45 | .79 |
| Caribbean | 249 | 70.0 | 0.75 | 0.60–0.94 | 0.77 | 0.61–0.98 | ||
| African | 181 | 69.1 | 0.74 | 0.57–0.96 | 0.71 | 0.54–0.93 | ||
| Any other Black background | 24 | 72.7 | 0.88 | 0.41–1.89 | .74 | 0.88 | 0.40–1.91 | .75 |
| Chinese | 93 | 69.9 | 0.76 | 0.53–1.10 | .15 | 0.72 | 0.50–1.06 | .09 |
| Any other ethnic group | 68 | 75.6 | 1.01 | 0.63–1.64 | .96 | 1.04 | 0.64–1.70 | .88 |
| (b) Given understandable written information about side effects of treatmente | ||||||||
| White | 40,568 | 82.6 | (ref)c | (ref)c | ||||
| Mixed | 195 | 80.6 | 0.87 | 0.64–1.20 | .41 | 0.71 | 0.51–0.99 | |
| Asian or Asian British | 705 | 77.6 | 0.73 | 0.62–0.85 | 0.64 | 0.54–0.75 | ||
| Black or Black British | 494 | 78.5 | 0.77 | 0.64–0.94 | 0.66 | 0.54–0.81 | ||
| Chinese | 102 | 76.1 | 0.67 | 0.45–1.00 | .05 | 0.51 | 0.34–0.78 | |
| Any other ethnic group | 73 | 82.0 | 0.96 | 0.56–1.65 | .86 | 0.73 | 0.42–1.28 | .27 |
| White British | 39,159 | 82.3 | (ref)d | (ref)d | ||||
| White Irish | 573 | 82.5 | 0.99 | 0.82–1.21 | .95 | 1.06 | 0.86–1.30 | .58 |
| Any other White background | 836 | 85.5 | 1.25 | 1.04–1.49 | 1.09 | 0.90–1.31 | .38 | |
| White & Black Caribbean | 52 | 78.8 | 0.79 | 0.44–1.42 | .42 | 0.68 | 0.37–1.26 | .25 |
| White & Black African | 23 | 79.3 | 0.81 | 0.33–1.99 | .65 | 0.64 | 0.25–1.64 | .35 |
| White & Asian | 67 | 81.7 | 0.94 | 0.54–1.65 | .84 | 0.72 | 0.40–1.28 | .26 |
| Any other Mixed background | 53 | 81.5 | 0.93 | 0.50–1.75 | .83 | 0.78 | 0.41–1.49 | .45 |
| Indian | 365 | 76.8 | 0.70 | 0.57–0.87 | 0.63 | 0.50–0.78 | ||
| Pakistani | 140 | 75.7 | 0.66 | 0.47–0.92 | 0.58 | 0.41–0.83 | ||
| Bangladeshi | 30 | 66.7 | 0.42 | 0.23–0.79 | 0.43 | 0.22–0.82 | ||
| Any other Asian background | 170 | 83.3 | 1.06 | 0.73–1.53 | .77 | 0.84 | 0.57–1.22 | .36 |
| Caribbean | 268 | 78.4 | 0.77 | 0.60–0.99 | 0.73 | 0.55–0.95 | ||
| African | 199 | 78.0 | 0.75 | 0.56–1.01 | .06 | 0.57 | 0.42–0.78 | |
| Any other Black background | 27 | 84.4 | 1.14 | 0.44–2.97 | .79 | 0.89 | 0.34–2.36 | .82 |
| Chinese | 102 | 76.1 | 0.67 | 0.45–1.00 | .05 | 0.51 | 0.34–0.78 | |
| Any other ethnic group | 73 | 82.0 | 0.96 | 0.56–1.65 | .86 | 0.73 | 0.42–1.28 | .27 |
| (c) Told about side effects that may develop in the futuref | ||||||||
| White | 25,505 | 55.4 | (ref)c | (ref)c | ||||
| Mixed | 122 | 51.9 | 0.87 | 0.67–1.13 | .29 | 0.83 | 0.64–1.8 | .16 |
| Asian or Asian British | 502 | 56.6 | 1.05 | 0.92–1.20 | .47 | 1.03 | 0.90–1.19 | .66 |
| Black or Black British | 314 | 50.9 | 0.84 | 0.71–0.98 | 0.80 | 0.68–0.95 | ||
| Chinese | 61 | 45.9 | 0.68 | 0.49–0.96 | 0.64 | 0.45–0.90 | ||
| Any other ethnic group | 49 | 56.3 | 1.04 | 0.68–1.59 | .84 | 1.10 | 0.71–1.70 | .66 |
| White British | 24,574 | 55.2 | (ref)d | (ref)d | ||||
| White Irish | 392 | 60.0 | 1.22 | 1.04–1.43 | 1.23 | 1.05–1.45 | ||
| Any other White background | 539 | 58.3 | 1.14 | 0.99–1.30 | .06 | 1.14 | 1.00–1.31 | .05 |
| White & Black Caribbean | 36 | 57.1 | 1.08 | 0.66–1.78 | .76 | 1.02 | 0.61–1.70 | .93 |
| White & Black African | 16 | 55.2 | 1.00 | 0.48–2.07 | .99 | 0.94 | 0.45–1.98 | .88 |
| White & Asian | 36 | 44.4 | 0.65 | 0.42–1.01 | .05 | 0.62 | 0.40–0.97 | |
| Any other Mixed background | 34 | 54.8 | 0.98 | 0.60–1.62 | .95 | 0.96 | 0.58–1.59 | .87 |
| Indian | 240 | 52.8 | 0.91 | 0.75–1.09 | .29 | 0.89 | 0.74–1.08 | .25 |
| Pakistani | 113 | 59.8 | 1.21 | 0.90–1.61 | .21 | 1.13 | 0.84–1.52 | .43 |
| Bangladeshi | 18 | 40.0 | 0.54 | 0.30–0.98 | 0.58 | 0.31–1.06 | .08 | |
| Any other Asian background | 131 | 66.2 | 1.59 | 1.18–2.13 | 1.61 | 1.19–2.17 | ||
| Caribbean | 164 | 48.7 | 0.77 | 0.62–0.95 | 0.76 | 0.61–0.95 | ||
| African | 133 | 53.6 | 0.94 | 0.73–1.20 | .61 | 0.87 | 0.67–1.13 | .30 |
| Any other Black background | 17 | 53.1 | 0..92 | 0.46–1.84 | .81 | 0.93 | 0.46–1.89 | .85 |
| Chinese | 61 | 45.9 | 0.68 | 0.49–0.96 | 0.64 | 0.45–0.90 | ||
| Any other ethnic group | 49 | 56.3 | 1.04 | 0.68–1.59 | .84 | 1.10 | 0.71–1.70 | .66 |
Note: Significant associations (p < .05) are highlighted in bold.
aAdjusted for age, gender, long-standing condition, time since first treatment, tumour group, patient classification, response to treatment, IMD quintile, Trust location (in/outside Greater London) and Trust.
bAnalysis was restricted to 52,029 respondents and excluded patients who did not respond to Q17 (n = 5031) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 11,677). According to the likelihood ratio test, the model using ethnic sub-categories was significantly better (at 95% confidence level) than the model using broad categories (χ 2(10) = 28.77, p = .001).
cFor comparisons by broad ethnic categories, the reference group was White patients.
dFor comparisons by ethnic sub-categories, the reference group was White British patients.
eAnalysis was restricted to 51,115 respondents and excluded patients who did not respond to Q18 (n = 6413) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 11,209). According to the likelihood ratio test, the model using ethnic sub-categories was not significantly better (at 95% confidence level) than the model using broad categories (χ 2(10) = 6.75, p = .75).
fAnalysis was restricted to 48,025 respondents and excluded patients who did not respond to Q19 (n = 10,230) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 10,482). According to the likelihood ratio test, the model using ethnic sub-categories was significantly better (at 95% confidence level) than the model using broad categories (χ 2(10) = 28.51, p = .002).
Receiving understandable answers to important questions from staff, by ethnicity.
| Ethnicity | % | OR | 95% CI | ORadja | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
| (a) Received an understandable answer from a clinical nurse specialistb | ||||||||
| White | 35,953 | 91.2 | (ref)c | (ref)c | ||||
| Mixed | 173 | 86.1 | 0.57 | 0.38–0.85 | 0.67 | 0.44–1.00 | .05 | |
| Asian or Asian British | 586 | 83.2 | 0.46 | 0.38–0.56 | 0.52 | 0.42–0.64 | ||
| Black or Black British | 437 | 83.7 | 0.48 | 0.38–0.60 | 0.57 | 0.44–0.72 | ||
| Chinese | 93 | 86.1 | 0.57 | 0.33–0.99 | 0.65 | 0.37–1.28 | 0.12 | |
| Any other ethnic group | 60 | 81.1 | 0.40 | 0.22–0.71 | 0.48 | 0.16–0.87 | ||
| White British | 34,745 | 91.6 | (ref)d | (ref)d | ||||
| White Irish | 496 | 88.6 | 0.71 | 0.55–0.92 | 0.76 | 0.58–0.99 | ||
| Any other White background | 712 | 90.6 | 0.88 | 0.69–1.12 | .30 | 0.98 | 0.77–1.26 | .90 |
| White & Black Caribbean | 45 | 81.8 | 0.41 | 0.21–0.82 | 0.48 | 0.24–0.97 | ||
| White & Black African | 19 | 86.4 | 0.58 | 0.17–1.96 | .38 | 0.63 | 0.18–2.16 | .46 |
| White & Asian | 57 | 87.7 | 0.65 | 0.31–1.37 | .26 | 0.78 | 0.37–1.66 | .52 |
| Any other Mixed background | 52 | 88.1 | 0.68 | 0.31–1.50 | .34 | 0.80 | 0.36–1.77 | .58 |
| Indian | 304 | 82.6 | 0.44 | 0.33–0.57 | 0.48 | 0.36–0.64 | ||
| Pakistani | 121 | 83.5 | 0.46 | 0.30–0.72 | 0.53 | 0.34–0.82 | ||
| Bangladeshi | 23 | 69.7 | 0.21 | 0.10–0.44 | 0.27 | 0.13–0.58 | ||
| Any other Asian background | 138 | 87.3 | 0.63 | 0.40–1.01 | .06 | 0.75 | 0.46–1.20 | .23 |
| Caribbean | 229 | 82.4 | 0.43 | 0.31–0.58 | 0.50 | 0.36–0.68 | ||
| African | 184 | 84.4 | 0.50 | 0.34–0.72 | 0.61 | 0.42–0.89 | ||
| Any other Black background | 24 | 92.3 | 1.01 | 0.26–4.65 | .90 | 1.32 | 0.31–5.65 | .71 |
| Chinese | 93 | 86.1 | 0.57 | 0.33–0.99 | 0.65 | 0.37–1.28 | .12 | |
| Any other ethnic group | 60 | 81.1 | 0.40 | 0.22–0.71 | 0.48 | 0.16–0.87 | ||
| (b) Received an understandable answer from a doctore | ||||||||
| White | 27,962 | 83.5 | (ref)c | (ref)c | ||||
| Mixed | 135 | 75.0 | 0.60 | 0.42–0.83 | 0.64 | 0.45–0.91 | ||
| Asian or Asian British | 427 | 69.3 | 0.45 | 0.38–0.53 | 0.49 | 0.41–0.59 | ||
| Black or Black British | 312 | 75.9 | 0.63 | 0.50–0.79 | 0.72 | 0.57–0.91 | ||
| Chinese | 68 | 70.8 | 0.48 | 0.31–0.75 | 0.51 | 0.32–0.81 | ||
| Any other ethnic group | 55 | 84.6 | 1.09 | 0.56–2.14 | .80 | 1.43 | 0.72–2.85 | .31 |
| White British | 27,007 | 83.5 | (ref)d | (ref)d | ||||
| White Irish | 407 | 84.3 | 1.06 | 0.83–1.36 | .65 | 1.11 | 0.86–1.42 | .43 |
| Any other White background | 548 | 80.5 | 0.81 | 0.67–0.99 | 0.88 | 0.72–1.07 | .20 | |
| White & Black Caribbean | 37 | 69.8 | 0.46 | 0.25–0.82 | 0.49 | 0.27–0.89 | ||
| White & Black African | 16 | 76.2 | 0.63 | 0.23–1.73 | .37 | 0.68 | 0.24–1.89 | .46 |
| White & Asian | 49 | 79.0 | 0.75 | 0.40–1.37 | .35 | 0.84 | 0.45–1.58 | .59 |
| Any other Mixed background | 33 | 75.0 | 0.59 | 0.30–1.17 | .13 | 0.62 | 0.31–1.24 | .18 |
| Indian | 226 | 71.8 | 0.50 | 0.39–0.64 | 0.53 | 0.41–0.59 | ||
| Pakistani | 97 | 68.8 | 0.44 | 0.31–0.62 | 0.49 | 0.34–0.71 | ||
| Bangladeshi | 11 | 33.3 | 0.12 | 0.05–0.20 | 0.14 | 0.07–0.30 | ||
| Any other Asian background | 93 | 73.2 | 0.54 | 0.36–0.80 | 0.58 | 0.40–0.88 | ||
| Caribbean | 165 | 73.3 | 0.54 | 0.40–0.73 | 0.64 | 0.47–0.87 | ||
| African | 132 | 78.6 | 0.73 | 0.50–1.05 | .09 | 0.81 | 0.55–1.18 | .27 |
| Any other Black background | 15 | 83.3 | 0.99 | 0.29–3.41 | .99 | 1.28 | 0.36–4.54 | .70 |
| Chinese | 68 | 70.8 | 0.48 | 0.31–0.75 | 0.51 | 0.32–0.81 | ||
| Any other ethnic group | 55 | 84.6 | 1.09 | 0.56–2.14 | .80 | 1.43 | 0.72–2.85 | .31 |
| (c) Received an understandable answer from a ward nursef | ||||||||
| White | 24,144 | 75.9 | (ref)c | (ref)c | ||||
| Mixed | 129 | 73.7 | 0.89 | 0.64–1.25 | .50 | 0.99 | 0.70–1.40 | .964 |
| Asian or Asian British | 370 | 61.9 | 0.52 | 0.44–0.61 | 0.60 | 0.50–0.71 | ||
| Black or Black British | 262 | 65.7 | 0.61 | 0.49–0.75 | 0.73 | 0.59–0.91 | ||
| Chinese | 60 | 59.4 | 0.46 | 0.31–0.69 | 0.53 | 0.35–0.79 | ||
| Any other ethnic group | 46 | 71.9 | 0.81 | 0.47–1.40 | .45 | 1.14 | 0.65–2.00 | .64 |
| White British | 23,319 | 76.0 | (ref)d | (ref)d | ||||
| White Irish | 343 | 75.4 | 0.97 | 0.78–1.20 | .77 | 1.04 | 0.83–1.29 | .76 |
| Any other White background | 482 | 73.7 | 0.87 | 0.74–1.06 | .18 | 1.01 | 0.84–1.21 | .91 |
| White & Black Caribbean | 37 | 71.2 | 0.78 | 0.43–1.42 | .42 | 0.85 | 0.46–1.56 | .60 |
| White & Black African | 13 | 72.2 | 0.82 | 0.30–2.31 | .71 | 0.85 | 0.30–2.44 | .77 |
| White & Asian | 48 | 80.0 | 1.27 | 0.67–2.38 | .47 | 1.48 | 0.77–1.51 | .23 |
| Any other Mixed background | 31 | 68.9 | 0.70 | 0.37–1.32 | .27 | 0.79 | 0.41–1.51 | .48 |
| Indian | 194 | 62.8 | 0.53 | 0.42–0.67 | 0.62 | 0.48–0.79 | ||
| Pakistani | 83 | 61.0 | 0.50 | 0.35–0.70 | 0.57 | 0.40–0.81 | ||
| Bangladeshi | 10 | 34.5 | 0.16 | 0.08–0.36 | 0.24 | 0.11–0.52 | ||
| Any other Asian background | 83 | 67.0 | 0.64 | 0.44–0.93 | 0.75 | 0.51–1.10 | .14 | |
| Caribbean | 139 | 65.9 | 0.61 | 0.46–0.81 | 0.76 | 0.57–1.03 | .07 | |
| African | 111 | 65.7 | 0.61 | 0.44–0.83 | 0.70 | 0.50–0.97 | ||
| Any other Black background | 12 | 63.2 | 0.54 | 0.31–0.69 | 0.69 | 0.26–1.79 | .44 | |
| Chinese | 60 | 59.4 | 0.46 | 0.31–0.69 | 0.53 | 0.35–0.79 | ||
| Any other ethnic group | 46 | 71.9 | 0.81 | 0.47–1.40 | .45 | 1.14 | 0.65–2.00 | .64 |
Note: Significant associations (p < .05) are highlighted in bold.
aAdjusted for age, gender, long-standing condition, time since first treatment, tumour group, patient classification, response to treatment, IMD quintile, Trust location (in/outside Greater London) and Trust.
bAnalysis was restricted to 40,880 respondents and excluded patients who did not respond to Q24 (n = 18,931) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 8926). According to the likelihood ratio test, the model using ethnic sub-categories was not significantly better (at 95% confidence level) than the model using broad categories according to the likelihood ratio test (χ 2(10) = 12.80, p = .24).
cFor comparisons by broad ethnic categories, the reference group was White patients.
dFor comparisons by ethnic sub-categories, the reference group was White British patients.
eAnalysis was restricted to 34,877 respondents and excluded patients who did not respond to Q37 (n = 26,507) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 7353). According to the likelihood ratio test, the model using ethnic sub-categories was significantly better (at 95% confidence level) than the model using broad categories according to the likelihood ratio test (χ 2(10) = 18.06, p = .05).
fAnalysis was restricted to 33,138 respondents and excluded patients who did not respond to Q41 (n = 28,685) or had missing data for age, gender, ethnicity, time since first treatment, long-standing condition status, response to treatment or IMD quintile (n = 6914). According to the likelihood ratio test, the model using ethnic sub-categories was not significantly better (at 95% confidence level) than the model using broad categories according to the likelihood ratio test (χ2(10) = 9.74, p = 0.47).
2012–2013 NCPES questions related to communication and information provision with details of the dichotomised responses.
| Positive | Negative | ||||||
|---|---|---|---|---|---|---|---|
| Stage of cancer care pathway | 13 | Did you understand the explanation of what was wrong with you? | Yes, I completely understood it | Yes, I understood some of it | No, I did not understand it | ||
| 14 | When you were told you had cancer, were you given written information about the type of cancer you had? | Yes, and it was easy to understand | Yes, but it was difficult to understand | No, I was not given written information about the type of cancer I had | |||
| 6 | Beforehand, did a member of staff explain the purpose of the test? | Yes, completely | Yes, to some extent | No, but I would have liked an explanation | |||
| 7 | Beforehand, did a member of staff explain what would be done during the test procedure? | Yes, completely | Yes, to some extent | No, but I would have liked an explanation | |||
| 8 | Beforehand, were you given written information about your test? | Yes, and it was easy to understand | Yes, but it was difficult to understand | No, but I would have liked written information about the test(s) | |||
| 9 | Were the results of the test(s) explained in a way you could understand? | Yes, completely | Yes, to some extent | No, but I would have liked an explanation | |||
| 17 | Were the possible side effects of treatment(s) explained in a way you could understand? | Yes, definitely | Yes, to some extent | No, side effects were not explained | |||
| 18 | Before you started your treatment, were you given written information about the side effects of treatment(s)? | Yes, and it was easy to understand | Yes, but it was difficult to understand | No, I was not given written information about side effects | |||
| 19 | Were you also told about any side effects of the treatment that could affect you in the future rather than straight away? | Yes definitely | Yes, to some extent | No, future side effects were not explained | |||
| 33 | Before you had your operation, did a member of staff explain what would be done during the operation? | Yes, completely | Yes, to some extent | No, but I would have liked an explanation | |||
| 34 | Beforehand, were you given written information about your operation? | Yes, and it was easy to understand | Yes, but it was difficult to understand | No, but I would have liked an explanation | |||
| 35 | After the operation, did a member of staff explain how it had gone in a way you could understand? | Yes, completely | Yes, to some extent | No, but I would have liked an explanation | |||
| 25 | Did hospital staff give you information about support or self-help groups for people with cancer? | Yes | No, but I would have liked information | ||||
| 26 | Did hospital staff discuss with you or give you information about the impact cancer could have on your work life or education? | Yes | No, but I would have liked a discussion or information | ||||
| 27 | Did hospital staff give you information about how to get financial help or any benefits you may be entitled to? | Yes | No, but I would have liked information | ||||
| 28 | Did hospital staff tell you that you could get free prescriptions? | Yes | No, but I would have liked information | ||||
| 53 | Were you given clear written information about what you should or should not do after leaving hospital? | Yes | No | ||||
| 54 | Did hospital staff tell you who to contact if you were worried about your condition or treatment after you left hospital? | Yes | No | ||||
| General | |||||||
| 24 | When you have important questions to ask your Clinical Nurse Specialist, how often do you get answers you can understand? | All or most of the time | Some of the time | Rarely or never | |||
| 37 | When you had important questions to ask a doctor, how often did you get answers that you could understand? | All or most of the time | Some of the time | Rarely or never | |||
| 41 | When you had important questions to ask a ward nurse, how often did you get answers you could understand? | All or most of the time | Some of the time | Rarely or never | |||
| 67 | How much information were you given about your condition and treatment? | The right amount | Not enough | Too much | |||
| 70 | Overall, how would you rate your NHS care? | Excellent | Very good | Good | Fair | Poor | |